Abstract Sarcopenia is increasingly recognized as a complication of type 2 diabetes mellitus (T2DM); however, simple screening tools for hospitalized older adults remain limited. The sarcopenia index (SI), calculated as serum creatinine (mg/dL)/cystatin C (mg/L) × 100, has been proposed as a readily available biomarker of muscle mass. However, its clinical utility and optimal cut-off value in older Chinese inpatients with T2DM are unclear.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Chenxi
Contact Chenxi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack